248 related articles for article (PubMed ID: 36990614)
1. Current drug development and trial designs in neuro-oncology: report from the first American Society of Clinical Oncology and Society for Neuro-Oncology Clinical Trials Conference.
Rahman R; Polley MC; Alder L; Brastianos PK; Anders CK; Tawbi HA; Mehta M; Wen PY; Geyer S; de Groot J; Zadeh G; Piantadosi S; Galanis E; Khasraw M
Lancet Oncol; 2023 Apr; 24(4):e161-e171. PubMed ID: 36990614
[TBL] [Abstract][Full Text] [Related]
2. Neuro-oncology: a selected review of ASCO 2016 abstracts.
Chamberlain MC
CNS Oncol; 2016 Oct; 5(4):193-8. PubMed ID: 27616612
[TBL] [Abstract][Full Text] [Related]
3. Neuro-oncology: a selected review of ASCO 2011 abstracts.
Chamberlain MC
Expert Rev Neurother; 2011 Oct; 11(10):1371-7. PubMed ID: 21955193
[TBL] [Abstract][Full Text] [Related]
4. Neuro-oncology: a selected review of ASCO 2012 abstracts.
Chamberlain MC
CNS Oncol; 2012 Nov; 1(2):127-30. PubMed ID: 25057862
[TBL] [Abstract][Full Text] [Related]
5. A selected review of abstracts from the 19th annual meeting of the Society for Neuro-Oncology.
Chamberlain MC
CNS Oncol; 2015; 4(3):125-9. PubMed ID: 25906288
[TBL] [Abstract][Full Text] [Related]
6. Leveraging external data in the design and analysis of clinical trials in neuro-oncology.
Rahman R; Ventz S; McDunn J; Louv B; Reyes-Rivera I; Polley MC; Merchant F; Abrey LE; Allen JE; Aguilar LK; Aguilar-Cordova E; Arons D; Tanner K; Bagley S; Khasraw M; Cloughesy T; Wen PY; Alexander BM; Trippa L
Lancet Oncol; 2021 Oct; 22(10):e456-e465. PubMed ID: 34592195
[TBL] [Abstract][Full Text] [Related]
7. Novel Clinical Trial Designs in Neuro-Oncology.
Saraf A; Trippa L; Rahman R
Neurotherapeutics; 2022 Oct; 19(6):1844-1854. PubMed ID: 35969361
[TBL] [Abstract][Full Text] [Related]
8. Seamless Designs: Current Practice and Considerations for Early-Phase Drug Development in Oncology.
Hobbs BP; Barata PC; Kanjanapan Y; Paller CJ; Perlmutter J; Pond GR; Prowell TM; Rubin EH; Seymour LK; Wages NA; Yap TA; Feltquate D; Garrett-Mayer E; Grossman W; Hong DS; Ivy SP; Siu LL; Reeves SA; Rosner GL
J Natl Cancer Inst; 2019 Feb; 111(2):118-128. PubMed ID: 30561713
[TBL] [Abstract][Full Text] [Related]
9. Editorial: advances in neuro-oncology and clinical treatment-from ASNO 2019.
Chen PY; Wei KC
J Neurooncol; 2020 Feb; 146(3):397-398. PubMed ID: 32020469
[TBL] [Abstract][Full Text] [Related]
10. The role of tumor board conferences in neuro-oncology: a nationwide provider survey.
Snyder J; Schultz L; Walbert T
J Neurooncol; 2017 May; 133(1):1-7. PubMed ID: 28421461
[TBL] [Abstract][Full Text] [Related]
11. Provider-reported challenges and barriers to referring patients to neuro-oncology clinical trials: a report from the Society for Neuro-Oncology member survey.
Rogers JL; Acquaye A; Vera E; Bates A; Wen PY; Armstrong TS
Neurooncol Pract; 2020 Jan; 7(1):38-51. PubMed ID: 32257283
[TBL] [Abstract][Full Text] [Related]
12. Updates from the 2013 Society for Neuro-Oncology annual and World Federation for Neuro-Oncology quadrennial meeting.
Lukas RV; Amidei C
Tumori; 2014; 100(3):358-62. PubMed ID: 25076251
[TBL] [Abstract][Full Text] [Related]
13. A selected review of abstracts from the 11th Congress of the European Association of Neuro-Oncology (EANO).
Chamberlain MC
CNS Oncol; 2015; 4(1):5-9. PubMed ID: 25586421
[TBL] [Abstract][Full Text] [Related]
14. A selected review of abstracts from the 17th Annual Scientific Meeting of the Society for Neuro-Oncology.
Chamberlain MC
CNS Oncol; 2013 Mar; 2(2):117-20. PubMed ID: 25057974
[TBL] [Abstract][Full Text] [Related]
15. Conference scene: Neuro-oncology insights from European Society of Medical Oncology 2012.
Marosi C
CNS Oncol; 2013 Jan; 2(1):29-31. PubMed ID: 25054356
[TBL] [Abstract][Full Text] [Related]
16. Unique challenges for glioblastoma immunotherapy-discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Meeting Report from the 2019 SNO Immuno-Oncology Think Tank.
Chuntova P; Chow F; Watchmaker PB; Galvez M; Heimberger AB; Newell EW; Diaz A; DePinho RA; Li MO; Wherry EJ; Mitchell D; Terabe M; Wainwright DA; Berzofsky JA; Herold-Mende C; Heath JR; Lim M; Margolin KA; Chiocca EA; Kasahara N; Ellingson BM; Brown CE; Chen Y; Fecci PE; Reardon DA; Dunn GP; Liau LM; Costello JF; Wick W; Cloughesy T; Timmer WC; Wen PY; Prins RM; Platten M; Okada H
Neuro Oncol; 2021 Mar; 23(3):356-375. PubMed ID: 33367885
[TBL] [Abstract][Full Text] [Related]
17. Current state of therapeutic focused ultrasound applications in neuro-oncology.
Meng Y; Pople CB; Budiansky D; Li D; Suppiah S; Lim-Fat MJ; Perry J; Sahgal A; Lipsman N
J Neurooncol; 2022 Jan; 156(1):49-59. PubMed ID: 34661791
[TBL] [Abstract][Full Text] [Related]
18. US Food and Drug Administration regulatory updates in neuro-oncology.
Mehta GU; Barone AK; Bradford D; Larkins E; Kim J; Pai-Scherf L; Jaigirdar A; Shah M; Wedam S; Amiri-Kordestani L; Theoret MR; Pazdur R; Beaver JA; Singh H
J Neurooncol; 2021 Jul; 153(3):375-381. PubMed ID: 34156585
[TBL] [Abstract][Full Text] [Related]
19. Highlights of the 2019 Society for Neuro-Oncology Inaugural Brain Metastases Conference: establishing a dedicated meeting to address an unmet need in the field.
Zuccato JA; Aizer AA; Lee EQ; Ahluwalia MS; O'Halloran PJ; Mansouri A; Wen PY; Zadeh G
Neurooncol Adv; 2020; 2(1):vdaa036. PubMed ID: 32793883
[TBL] [Abstract][Full Text] [Related]
20. Phase 2 trial design in neuro-oncology revisited: a report from the RANO group.
Galanis E; Wu W; Cloughesy T; Lamborn K; Mann B; Wen PY; Reardon DA; Wick W; Macdonald D; Armstrong TS; Weller M; Vogelbaum M; Colman H; Sargent DJ; van den Bent MJ; Gilbert M; Chang S
Lancet Oncol; 2012 May; 13(5):e196-204. PubMed ID: 22554547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
